diabetes - search results

Researchers from the University of Oxford and Novo Nordisk are collaborating to develop better treatments for type 2 diabetes

Head of Policy, Knowledge and Insight at Diabetes UK, Robin Hewings sheds light on the condition of diabetes in the UK today.

Hitachi Consulting sheds light on how they digitally enable type 2 diabetes prevention models

John J. Nolan, Stefano Del Prato, Juleen R. Zierath from the European Association for the Study of Diabetes e.V. present their approach to address the pandemic of diabetes in Europe today

University of Oulu’s Professor Riitta Veijola discusses the impact of Type 1 diabetes on society and the challenges associated with tackling the disease

Ai-Ling Lin, Ph.D, Assistant Professor, Sanders-Brown Center on Aging, University of Kentucky discusses Alzheimer's disease and the link to diabetes and nutrition... Alzheimer’s disease (AD) is the most common form of dementia in those over the age of 65, and currently ranked as the sixth leading cause of death in the United...

Dr Justin Warner, Clinical Lead for the National Paediatric Diabetes Audit at the Royal College of Paediatrics and Child Health details how continued improvements in diabetes care for children is needed in England and Wales… According to latest statistics, the outcomes for children and young people with type 1 diabetes...

The number of children developing type-2 diabetes, a disease usually linked to obesity, is on the rise… New research has revealed a growth in the number of children developing type-2 diabetes. Type-2 diabetes is usually seen in adults and is linked to obesity, unlike type-1 diabetes, which manifests in childhood and...

According to the Health and Social Care Information Centre, prescriptions for diabetes account for almost 10 per cent of the NHS primary care drugs budget in England. The Health and Social Care Information Centre (HSCIC) has revealed that almost 10 per cent of the NHS primary care drugs budget in...

Dr Renee J. Dufault, Executive Director at the Food Ingredient and Health Research Institute, explains the significance of nutritional epigenetics in understanding the impact of nutrients and dietary chemicals on gene expression patterns, as well as their role in the development of conditions such as autism and ADHD.

Thomas J. Webster, PhD provides a firsthand account of the obstacles hindering innovation in medicine, covering publishing, conferences, politics, funding, universities, and industry.

Neurological diseases are the foremost cause of ill health and disability worldwide. Open Access Government offers an overview of the prevalence of these conditions.

Ashley V. Makela and Christopher H. Contag from the Institute for Quantitative Health Science and Engineering, walk us through watching living therapeutics in action, including what imaging reveals about engineered endosymbionts.

Despite its prevalence and impact, PCOS remains an under-recognized, under-diagnosed, and under-funded condition. Sasha Ottey and Katherine Sherif explain why this approach to the condition must change.

Two seasoned experts from CPI, Medicines Manufacturing Innovation Centre, detail how the “tides” have turned in pharma manufacturing.

63.8% of the UK population are currently overweight or obese. Obesity is a major cause of ill health. Being moderately obese takes around 3 years off your life, whereas severe obesity shortens it by at least 10 years.

Asal Shirazi, Founder and CEO of the Autoimmune Support and Awareness (ASA) Foundation, explains the challenges in detecting, diagnosing and managing autoimmune conditions.

Global life expectancy is set to rise significantly by 2050, according to the latest findings from the Global Burden of Disease Study (GBD) 2021.

A new report from the Global Burden of Diseases, Injuries, and Risk Factors Study (GBD) 2021, shows the escalating health challenges seen by metabolic risk factors.

Lisa Artis, Deputy CEO at The Sleep Charity outlines the drivers and impact of poor sleep and why sleep deprivation must be considered a public health priority.